Recent NVO News
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 05/22/2026 06:32:50 PM
- Form SD - Specialized disclosure report • Edgar (US Regulatory) • 05/22/2026 04:29:54 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 05/22/2026 02:01:32 PM
- Eli Lilly shares rise after strong late-stage obesity drug trial results (LLY) • IH Market News • 05/21/2026 12:49:05 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 05/18/2026 02:29:05 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 05/13/2026 11:53:54 AM
- Novo Nordisk (NVO) Reports Strong Weight-Loss Results for Higher-Dose Wegovy • IH Market News • 05/12/2026 02:43:35 PM
- The $59B Quiet Shift Reshaping How Patients Access Care • PR Newswire (US) • 05/12/2026 02:30:00 PM
- The $59B Quiet Shift Reshaping How Patients Access Care • PR Newswire (Canada) • 05/12/2026 02:30:00 PM
- The Next Generation of the GLP-1 Revolution Is Already Underway • InvestorsHub NewsWire • 05/11/2026 01:00:00 PM
- The Next Generation of the GLP-1 Revolution Is Already Underway • GlobeNewswire Inc. • 05/11/2026 12:30:00 PM
- Biotech’s Next Wave May Already be in Motion • GlobeNewswire Inc. • 05/07/2026 12:45:00 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 05/06/2026 11:51:16 AM
- Novo Nordisk (NVO) lifts 2026 outlook as obesity drug demand remains strong • IH Market News • 05/06/2026 10:35:29 AM
- European equities advance while oil declines after Trump pauses Hormuz operation: DAX, CAC, FTSE100 • UK Market News • 05/06/2026 09:19:36 AM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 05/05/2026 01:30:07 PM
- Novo Nordisk’s Weight-Loss Pill Momentum Faces Pricing Pressure • IH Market News • 05/05/2026 10:27:23 AM
- Novo Nordisk Teams Up With OpenAI to Accelerate Drug Development • IH Market News • 04/14/2026 10:05:51 AM
- UK regulator recommends Novo Nordisk’s Wegovy to help reduce cardiovascular risks • IH Market News • 04/01/2026 02:03:29 PM
- Weight Watchers introduces discounted Wegovy pricing through Novo Nordisk partnership • IH Market News • 03/31/2026 02:53:43 PM
- Novo Nordisk introduces discounted Wegovy subscription plan in the U.S. • IH Market News • 03/31/2026 02:46:32 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 03/27/2026 11:47:17 AM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 03/27/2026 10:33:06 AM
- Novo Nordisk and United Laboratories report encouraging phase 2 results for diabetes drug UBT251 • IH Market News • 03/25/2026 10:54:15 AM
- FDA approves Novo Nordisk's new Wegovy® HD injection, delivering the highest weight loss to date for a Wegovy® injection, adding to its already expansive clinical profile • PR Newswire (US) • 03/19/2026 04:04:00 PM
